This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Under-$10 Stocks Set to Soar

BioCryst Pharmaceuticals

One under-$10 name in the biotechnology and drugs complex that could be putting in a bottom here is BioCryst Pharmaceuticals (BCRX). This company designs, optimizes and develops novel drugs that block enzymes involved in cancer, viral infections and autoimmune diseases. This stock has taken it on the chin in 2011 with shares off by over 50%.

If you take a look at the chart for BioCryst Pharmaceuticals, you'll notice that this stock has dropped sharply from its October high of $3.33 to a recent low of $2.28 a share. That recent drop has taken the stock down to retest a previous support zone from back in August at around $2.30 a share. If BCRX can manage to hold up around these levels, it could easily be putting in a near-term bottom. This potential bottom could offer a decent risk-to-reward rebound trade since the stock has spiked a number of times up to $3.40 to $3.30, whenever its hit $2.40 to $2.30 in the past few months.

Once could be a buyer of this stock off any noticeable weakness and simply use a mental stop a few percentage points below that $2.30 a share. Look for confirmation of a bottom if we start to see some decent upside volume in the near future. Volume should be considered bullish if the stock is moving higher and it's tracking in close to or above its three-month average action of 162,783 shares. Volume so far today is at 93,000, which is a bit light, so watch to see if that volume gets better into the close, or in the next few trading sessions.

BioCryst Pharmaceuticals is also another heavily shorted name since around 11% of their tradable float is currently sold short by the bears. If this stock is truly putting in a bottom, then look for those bears to cover some of their short positions and lock in profits.

4 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs